Clinical Trials List
2023-05-01 - 2027-12-31
Phase III
Recruiting4
ICD-10C71.0
Malignant neoplasm of cerebrum, except lobes and ventricles
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9191.0
Malignant neoplasm of cerebrum, except lobes and ventricles
-
Trial Applicant
TAIWAN BIOTECH CO., LTD.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/08/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YI YEN LEE Division of Orthopedics
- 李家誠 Division of Radiation Therapy
- 林可瀚 Division of Nuclear Medicine
- Chun-Fu Lin Division of Orthopedics
- 張豐基 Division of Neurology
- 許秉權 Division of Orthopedics
- 李家誠 Division of Radiation Therapy
- 吳智君 Division of Neurology
- 黃婉如 Division of Rehabilitation Medicine
- Chun-Yu Liu Division of Hematology & Oncology
- 藍天立 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Chieh Wang Division of Radiation Therapy
- 白冰清 Division of Radiation Therapy
- 李丞騏 Division of Orthopedics
- 林亞銳 Division of Orthopedics
- 林信吟 Division of Radiation Therapy
- Chi-Cheng Chuang Division of Orthopedics
- 陳科廷 Division of Orthopedics
- 曾振淦 Division of Radiation Therapy
- 蔡宏杰 Division of Orthopedics
- 盧郁仁 Division of Orthopedics
- Kuo-Chen Wei Division of Orthopedics
- 李家誠 無
- 李紳豪
- 杜振豐 Division of Radiology
- 林信男 Division of Radiology
- 黃盈誠 Division of Orthopedics
- 葉智華 Division of Radiology
- 蕭庭毅 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
55 participants
-
Global
55 participants
